CNI103

CNI103 is a metabolically stable, potent small molecule inhibitor that selectively disrupts the calcineurin-NFATc3 interaction (KD=16 nM) . It effectively blocks NFATc3 activation in both cellular and animal models, making it a valuable research tool for studying inflammatory pathologies such as acute respiratory distress syndrome (ARDS) .